Massberg and colleagues provide evidence demonstrating SphK2 expression, regulates platelet aggregation and that deletion of SphK2 leads to reduced arterial thrombosis after vascular injury, suggesting SphK2 is a potentially important target for protection against arterial thrombosis [73, 74]. The gene discussed is SPHK2; the disease is deep vein thrombosis.